Key players in the pharmaceutical business have come together to discuss current issues and exchange opinions gavel-to-gavel.

The participants exchanged their views and thoughts on the work of the pharmaceutical industry in the new environment, discussed what legislative initiatives had emerged, and whether they would survive the pandemic, whether the approach to the development and research of new medications had changed.

Maxim Stetsyuk, Executive Director of NANOLEK, took part in the Round Table Talk: “PHARMACEUTICAL MARKET IN RUSSIA IN THE AGE OF UNCERTAINTY: HOW TO LIVE ETHNIC BUT PRACTICAL LIFE?

He told how, in his opinion, the world would change after the coronavirus pandemic and what changes in legislation await the pharmaceutical business.

Interesting quotes:

“Certainly, the crisis will change approaches in business. Even now, many are reconsidering their costs and managing to assess whether or not employees’ transition to remote access was successful.”

“In general, the pharmaceutical market has received an incentive for development, but each segment reacts differently. Pharma is a regulated industry, and some processes have accelerated, while the others slowed down.”

“As regards legislative initiatives, we have room to develop the National Preventive Vaccination Calendar (NPVC) and, following the example of many countries, adopting their experience, switch to the use of combined vaccines that can reduce the injection burden on children. For example, one vaccine can protect against five infections at the same time.”